Upcoming ABT earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
October 13, 2026before market open
Abbott Laboratories is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
Abbott Laboratories reported 13.0% net sales growth to $12.6B in Q2 2026, driven primarily by the $20.6B acquisition of Exact Sciences (now reported as Cancer…
ABT delivered 7.8% revenue growth to $11.16B in Q1 FY2026, but net income fell 18.7% to $1.08B as a 22.2% surge in SG&A expenses and a 132.7% jump in long-term…
Abbott Laboratories delivered solid FY2025 operating performance with revenue up 5.7% to $44.3B and operating income surging 18.0% to $8.1B, though reported…
Abbott Laboratories (ABT) is scheduled to report earnings on October 13, 2026, before market open, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Abbott Laboratories's most recent earnings report was its Q2 2026 10-Q, filed with the SEC on July 28, 2026.
EarningsLens publishes free AI analysis of every ABT 10-K and 10-Q filing. The latest covers Q2 2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Abbott Laboratories reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.